All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-YJ344 | Anti-TRAIP (1G3) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1G3 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ345 | Anti-TRAIP (1G9) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 1G9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ346 | Anti-TRAIP (2D4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2D4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ347 | Anti-TRAIP (2E7) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 2E7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ348 | Anti-TRAIP (3A4) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | 3A4 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ844 | Anti-TRAIP (1G3) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1G3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ845 | Anti-TRAIP (1G9) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1G9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ846 | Anti-TRAIP (2D4) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2D4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ847 | Anti-TRAIP (2E7) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2E7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-YJ848 | Anti-TRAIP (3A4) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 3A4 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-0320ZP2268 | Anti-TRAIP (2E7) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 2E7 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION